logo     Print Page  Close Window

Investor Overview

KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.

 

Stock Quote
KMPH (Common Stock)
PriceChange% ChangeVolume
$3.35 - 0.051.47%23,742
Previous CloseToday's OpenIntraday HighIntraday Low
$3.40$3.45$3.48$3.35
Exchange: NASDAQ (US Dollar)
06/23/17 4:00 p.m. ET
Refresh quote
Recent NewsMore >>
06/09/17
KemPharm to Present Clinical Data for KP511, an Opioid Prodrug Candidate, at the International Conference on Opioids
06/01/17
KemPharm Announces Addition to Leadership Team
05/10/17
KemPharm, Inc. Reports First Quarter 2017 Results
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources